ONCAlert | Upfront Therapy for mRCC
Latest From Florida Cancer Specialists
FCS Names Shekeab Jauhari as Principal Investigator for their New Drug Development Unit
2:00 PM, Thu December 26, 2019
Discussing the Benefits of Trilaciclib Plus Topotecan for Treatment of Extensive-stage SCLC
6:41 PM, Tue August 27, 2019
FCS and Cigna Create New Initiative Focused on Better Patient Experience
4:49 PM, Fri August 23, 2019
Susmitha Apuri, MD, Joins Florida Cancer Specialists
5:00 PM, Sun June 30, 2019
Costs at Hospital-Based Oncology Practices Continue to Outpace Those of Community Cancer Clinics
7:56 PM, Thu June 13, 2019
Despite Initial Challenges, Oncology Practices See Benefit Moving to Oncology Care Model
2:58 PM, Tue May 14, 2019
Patient Misconceptions About Clinical Trials Are a Common Source of Resistance, Expert Panel Says
2:50 PM, Mon April 8, 2019
Taking on the Hospital/Community Practice Cost Differential
8:54 PM, Tue January 23, 2018
